Page last updated: 2024-08-18

thiophenes and Deep Vein Thrombosis

thiophenes has been researched along with Deep Vein Thrombosis in 123 studies

Research

Studies (123)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.81)	18.2507
2000's	26 (21.14)	29.6817
2010's	96 (78.05)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nieto Rodríguez, JA	1
Huo, MH; Russell, RD	1
Ageno, W; Buller, H; Glazer, S; Gunn, S; Peerlinck, K; Prins, M; Sonesson, E; Tangelder, M; Vanassche, T; Vandenbriele, C; Verhamme, P	1
Beauloye, C; Dogné, JM; Douxfils, J; Goethals, M; Hainaut, P; Heidbuchel, H; Hermans, C; Ickx, B; Jochmans, K; Michel, S; Mottes, S; Mullier, F; Peeters, A; Scavée, C; Sinnaeve, P; Sprynger, M; Thijs, V; Vandenbroeck, C; Vandermeulen, E; Verhamme, P	1
Peeters, S; Warnez, M	1
Arya, R; Chitongo, PB; Patel, JP; Patel, RK; Roberts, LN	1
Vanassche, T; Verhamme, P	1
Bamber, L; Bauersachs, R; Cano, SJ; Ciniglio, C; Lensing, AW; Prins, MH; Wang, MY	1
Babatz, J; Beyer-Westendorf, J; Pannach, S	1
Díaz de Rada, P; González, AB; Muñoa, L; Valentí, A; Valentí, JR	1
Wanat, MA	1
Atar, D; Ghanima, W; Sandset, PM	1
Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V	1
Beyer-Westendorf, J; Gehrisch, S	1
Bookhart, BK; Coleman, CI; Huynh, L; Lefebvre, P; Mody, SH; Nutescu, EA; Tran, KN; Wang, ST; Zhuo, DY	1
Degirmenci, SE; Steib, A	1
Wood, P	1
Baruch, L; Sherman, O	1
Aihara, K; Iba, T; Nagayama, M; Ohsaka, A; Tabe, Y; Yamada, A	1
Baker, R; Herrmann, R; Muhammad, S; Phillips, M; Thom, J; Wood, A	1
Martinez, M; Tandra, A; Vuppalanchi, R	3
Burness, CB; Perry, CM	1
Bamber, L; Correa de Carvalho, F; Lensing, AW; Prins, M; van Bellen, B; Wang, M	1
Rondina, MT; Vazquez, S; Vo, T	1
Alhenc-Gelas, M; Potaczek, DP; Undas, A; Wypasek, E	1
Heit, JA; Rooke, TW; Rosenbaum, AN; Yu, RC	1
García de Frutos, P; Tàssies, D	1
Cheng, W; Kan, W; Ren, Y; Xiao, Z; Xu, H; Zheng, Q	1
Sun, K; Tian, S; Wang, Y; Zou, Y	1
Bookhart, B; Huynh, L; Lefebvre, P; Mody, SH; Tran, KN; Zhuo, DY	1
den Exter, PL; Huisman, MV; Klok, FA; Kooiman, J; van der Hoeven, JJ; van der Hulle, T	1
Caldwell, SH; Intagliata, NM; Maitland, H; Northup, PG	1
Ng, HJ; Teo, EC; Than, H	1
Cappato, R; Davies, DW; Fields, LE; Hess, S; Hohnloser, SH; Ma, C; Marchlinski, FE; Naccarelli, GV; Natale, A; Wilber, DJ; Xiang, J	1
Piazza, G	1
Barinov, VE; Boiarintsev, VV; Lobastov, KV; Schastlivtsev, IV	1
Baumann, M; Ceschi, A; Hasler, K; Hofer, KE; Korte, W; Kupferschmidt, H; Lehmann, T; Rohde, G	1
Bamber, L; Bookhart, BK; Haskell, L; Mody, SH; Schein, J; Wang, M	1
Geisbüsch, C; Herweh, C; Nagel, S; Richter, D; Ringleb, PA	1
Adelmeijer, J; Lisman, T; Potze, W	1
Akwaa, F; Spyropoulos, AC	1
Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE	1
Heim, M; Krähenbühl, S; Liakoni, E; Rätz Bravo, AE; Terracciano, L	1
Kamath, PS; Simonetto, DA; Wysokinski, WE	1
Aupetit, JF; Chaudesaygues, E; Grasse, M; Marchand, L; Villar, E	1
Buder, R; Dieplinger, B; Lenz, K; Piringer, P; Rauch, M; Voglmayr, M	1
Frolov, DV; Linchenko, DV; Poliantsev, AA; Shchelokova, IuV	1
Berman, B; Bray, N; Katz, H; Popov, E	1
Esmon, N; Grant, R; Marlar, RA; Mauer, K; Rathbun, S; Tafur, A	1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM	1
Bultas, J; Karetová, D	1
Bakchoul, T; Ganzel, C; Greinacher, A; Rowe, JM; Tvito, A	1
Bodó, I; Iványi, JL; Plander, M; Szendrei, T	1
Chen, B; Huang, CC; Kuo, FC; Lin, PC; Wang, JW; Yen, SH	1
Bansal, VB; Donovan, A; Gollish, JD; Gomez, D; Murnaghan, JJ; Razmjou, H	1
Cushner, FD; Eriksson, BI; Friedman, RJ; Lassen, MR	1
Bandel, TJ; Beckmann, H; Borris, LC; Eriksson, BI; Friedman, RJ; Geerts, W; Haas, S; Huisman, MV; Kakkar, AK; Misselwitz, F; Muehlhofer, E	1
Ageno, W; Bandel, TJ; Borris, LC; Lassen, MR; Lieberman, JR; Misselwitz, F; Rosencher, N; Turpie, AG	1
Becker, RC; Lohrmann, J	1
Agnelli, G; Buller, HR; Cohen, A; Gallus, AS; Lensing, AW; Misselwitz, F; Prins, MH; Raskob, G; Schellong, S; Segers, A	1
Ferrandis, R; Llau, JV; López Forte, C; Sapena, ML	1
Laporte, S; Mismetti, P	1
Albaladejo, P	1
Tripodi, A; van den Besselaar, A	1
Brighton, TA; Verma, AK	1
Bandel, TJ; Bauer, KA; Benson, A; Berkowitz, SD; Cushner, FD; Davidson, BL; Fisher, WD; Gent, M; Kwong, LM; Lassen, MR; Lotke, PA; Misselwitz, F; Turpie, AG	1
Crain, EJ; Watson, CA; Wong, PC; Xin, B	1
Stief, T	1
Dimmitt, S; Eikelboom, JW; Raju, NC	1
Blázquez-Pérez, A; Gómez-Outes, A; Pozo-Hernández, C; Suárez-Gea, ML; Vargas-Castrillón, E	1
Apostolakis, S; Lip, GY; Shantsila, E	1
Becker, RC; Mackman, N	1
Kubitza, D; Laux, V; Mueck, W; Perzborn, E; Roehrig, S; Straub, A	1
Fujimoto, T; Hiroe, K; Imaeda, Y; Kawamura, M; Konishi, N; Kubo, K; Shofuda, K	1
Lowenthal, DT; Sattari, M	1
Mousa, SA	1
Hiroe, K; Kawamura, M; Konishi, N	1
Alban, S; Völler, H; Westermann, D	1
Agnelli, G; Bauersachs, R; Berkowitz, SD; Bounameaux, H; Brenner, B; Buller, HR; Cohen, A; Davidson, BL; Decousus, H; Gallus, AS; Lensing, AW; Misselwitz, F; Piovella, F; Prins, MH; Raskob, GE; Schellong, S; Segers, A; Verhamme, P; Wells, P	1
Kwok, CS; Loke, YK	1
Büller, HR; Cohen, AT; Haskell, L; Hu, D; Hull, R; Mebazaa, A; Merli, G; Schellong, S; Spiro, TE; Spyropoulos, A; Tapson, V	1
Gans, RO; Landman, GW	1
Nunnelee, JD	1
Thompson, CA	1
Arya, R; Patel, JP; Roberts, LN	1
Agnelli, G; Decousus, H; Lensing, AW; Misselwitz, F; Mueck, W; Prandoni, P	1
de Jong, H; Kluin-Nelemans, H; Meijer, K; Mulder, A; Nijland, H; Tichelaar, V	1
Galanis, T; Kraft, WK; Merli, GJ	1
Fassiadis, N	1
Büller, HR; Combe, S	1
Cid, A; Godoy Monzon, D; Iserson, KV; Vazquez, JA	1
Favaloro, EJ; Lippi, G	1
Erdle, S; Harenberg, J; Krämer, R; Marx, S	1
Einecke, D	1
Hui, AC; James, P; Jameson, SS; Muller, SD; Rymaszewska, M; Serrano-Pedraza, I	1
DeDea, L	1
Schulman, S	1
Haas, S; Kreutz, R; Llau, J; Norrving, B; Turpie, AG	1
Haynes, LM; Mann, KG; Orfeo, T	1
Esmon, CT	1
Elias, A; Gaillard, C; Gouin, I; Nguyen, P; Ouvry, P; Pernod, G; Sié, P	1
Lazo-Langner, A; Sun, D	1
Hannan, T; Khalafallah, AA; Renu, S; Sharp, C	1
Albuquerque, LG; Dini, GM; Ferreira, LM; Ferreira, MCC	1
Beyer-Westendorf, J; Donath, L; Günther, KP; Hartmann, A; Knoth, H; Kuhlisch, E; Lützner, J; Radke, OC; Stange, T; Tittl, L; Weiss, N; Werth, S	1
Kong, Y; Wang, G; Wang, L; Zhang, Y; Zhao, X	1
Coccheri, S; Orlando, D	1
Kitchen, S; Makris, M; Smith, J; van Veen, JJ	1
Perzborn, E; Pohlmann, J; Roehrig, S; Schlemmer, KH; Strassburger, J; Straub, A; Wilmen, A	1
Bauer, KA; Fisher, WD; Gent, M; Irwin, MW; Kälebo, P; Kwong, LM; Misselwitz, F; Turpie, AG	1
Borris, L; Dahl, OE; Eriksson, BI; Haas, S; Huisman, MV; Kakkar, AK; Kälebo, P; Misselwitz, F	1
Borris, LC; Dahl, OE; Eriksson, BI; Haas, S; Huisman, MV; Kakkar, AK; Kälebo, P; Misselwitz, F; Muehlhofer, E	1
Biemond, BJ; Buetehorn, U; Büller, HR; Friederich, PW; Levi, M; Perzborn, E	1
Beyer, J; Eriksson, BI; Halbritter, K; Kakkar, AK; Kälebo, P; Misselwitz, F; Schellong, SM; Turpie, AG	1
Ma, Q	1
Adler, M; Arnaiz, DO; Cheeseman, S; Chou, YL; Dole, WP; Ewing, J; Fitch, R; Griedel, BD; Karanjawala, R; Kochanny, MJ; Lee, W; Lentz, D; Liang, A; Light, D; Morrissey, MM; Morser, J; Post, J; Rumennik, G; Sacchi, KL; Sakata, ST; Shaw, KJ; Subramanyam, B; Sullivan, ME; Vergona, R; Walters, J; Wang, YX; White, KA; Whitlow, M; Wu, SC; Ye, B; Zhao, Z	1
Bauer, KA; Borris, L; Dahl, OE; Eriksson, BI; Fisher, WD; Gent, M; Haas, S; Homering, M; Huisman, MV; Kakkar, AK; Kälebo, P; Kwong, LM; Misselwitz, F; Turpie, AG	1
Bentley, R; Bostwick, JS; Brown, K; Chu, V; Dunwiddie, CT; Ewing, WR; Leadley, RJ; Morgan, S; Pauls, H; Perrone, MH; Spada, AP	1

Reviews

29 review(s) available for thiophenes and Deep Vein Thrombosis

Article	Year
[New approaches in the treatment of deep vein thrombosis]. Medicina clinica, 2012, Volume: 139 Suppl 2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis	2012
Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty. The Journal of arthroplasty, 2013, Volume: 28, Issue:9 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
[Oral Rivaroxaban (Xarelto)]. Journal de pharmacie de Belgique, 2013, Issue:1 Topics: Anticoagulants; Drug Interactions; Humans; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
Rivaroxaban for the treatment of pulmonary embolism. Advances in therapy, 2013, Volume: 30, Issue:6 Topics: Administration, Oral; Anticoagulants; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2013
Rivaroxaban is as efficient and safe as bemiparin as thromboprophylaxis in knee arthroscopy. Musculoskeletal surgery, 2014, Volume: 98, Issue:1 Topics: Adult; Aged; Arthroscopy; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Knee Joint; Male; Middle Aged; Morpholines; Polypharmacy; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Rivaroxaban; Therapeutic Equipoise; Thiophenes; Thrombophilia; Venous Thrombosis	2014
Novel oral anticoagulants: a review of new agents. Postgraduate medicine, 2013, Volume: 125, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
New oral anticoagulants--a review. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Oct-01, Volume: 133, Issue:18 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities. European journal of internal medicine, 2014, Volume: 25, Issue:1 Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin	2014
Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism. Drugs, 2014, Volume: 74, Issue:2 Topics: Anticoagulants; Factor Xa Inhibitors; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2014
Current state of anticoagulants to treat deep venous thrombosis. Current cardiology reports, 2014, Volume: 16, Issue:3 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Patient Selection; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis	2014
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism. Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:7 Topics: Acute Disease; Administration, Oral; Anticoagulants; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Morpholines; Neoplasms; Randomized Controlled Trials as Topic; Recurrence; Risk; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2014
The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism. Current medical research and opinion, 2014, Volume: 30, Issue:11 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2014
[Anaesthesia and thromboembolic disease]. Medicina clinica, 2008, Volume: 131 Suppl 2 Topics: Acenocoumarol; Administration, Oral; Anesthesia, Conduction; Anticoagulants; Benzimidazoles; Clinical Protocols; Dabigatran; Early Ambulation; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Risk Factors; Rivaroxaban; Safety; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2008
[Rivaroxaban: clinical pharmacology]. Annales francaises d'anesthesie et de reanimation, 2008, Volume: 27 Suppl 3 Topics: Administration, Oral; Aged; Anticoagulants; Biological Availability; Clinical Trials as Topic; Contraindications; Cytochrome P-450 CYP3A; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Metabolic Clearance Rate; Middle Aged; Molecular Structure; Morpholines; Orthopedic Procedures; Postoperative Complications; Preanesthetic Medication; Rivaroxaban; Thiophenes; Venous Thrombosis	2008
Laboratory monitoring of anticoagulation: where do we stand? Seminars in thrombosis and hemostasis, 2009, Volume: 35, Issue:1 Topics: Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Incidence; International Normalized Ratio; Monitoring, Physiologic; Morpholines; Polysaccharides; Prothrombin Time; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Vitamin K	2009
Rivaroxaban: a new oral factor Xa inhibitor. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:3 Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2010
Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Drug Approval; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; United States; Venous Thrombosis	2011
Oral direct factor Xa inhibitors, with special emphasis on rivaroxaban. Methods in molecular biology (Clifton, N.J.), 2010, Volume: 663 Topics: Administration, Oral; Animals; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Factor Xa Inhibitors; Humans; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2010
[Do orally active factor Xa (FXa) inhibitors have potential as innovative new anticoagulants? Future perspective from preclinical data]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2010, Volume: 136, Issue:2 Topics: Animals; Anticoagulants; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Humans; Intracranial Thrombosis; Macaca fascicularis; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis	2010
[New oral anticoagulants: better than vitamin K antagonists?]. Der Internist, 2010, Volume: 51, Issue:12 Topics: Anticoagulants; Antithrombin Proteins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis; Vitamin K	2010
Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison. Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2011
Anticoagulating obese patients in the modern era. British journal of haematology, 2011, Volume: 155, Issue:2 Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Humans; Morpholines; Multicenter Studies as Topic; Obesity; Polysaccharides; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Venous Thrombosis; Warfarin	2011
Rivaroxaban (Xarelto)--a new oral anticoagulant. The Medical letter on drugs and therapeutics, 2011, Aug-22, Volume: 53, Issue:1371 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Drug Interactions; Factor Xa Inhibitors; Humans; Morpholines; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thrombosis	2011
Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. Advances in surgery, 2011, Volume: 45 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Neurosurgical Procedures; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stockings, Compression; Surgical Procedures, Operative; Thiophenes; Urologic Surgical Procedures; Venous Thrombosis	2011
Advances in the management of venous thromboembolism. Best practice & research. Clinical haematology, 2012, Volume: 25, Issue:3 Topics: Anticoagulants; Antithrombins; Clinical Trials as Topic; Diagnostic Imaging; Disease Management; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Morpholines; Radiography; Risk; Rivaroxaban; Thiophenes; Thrombin; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin	2012
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor. Thrombosis and haemostasis, 2012, Volume: 108, Issue:5 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Practice Guidelines as Topic; Pregnancy; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin	2012
What did we learn from new oral anticoagulant treatment? Thrombosis research, 2012, Volume: 130 Suppl 1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Half-Life; Hemorrhage; Humans; Metabolic Clearance Rate; Morpholines; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2012
New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures. Internal and emergency medicine, 2013, Volume: 8, Issue:2 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2013
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thrombosis and haemostasis, 2007, Volume: 97, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dose-Response Relationship, Drug; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Incidence; Male; Middle Aged; Morpholines; Phlebography; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2007

Trials

20 trial(s) available for thiophenes and Deep Vein Thrombosis

Article	Year
Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial. Thrombosis and haemostasis, 2013, Volume: 109, Issue:6 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Arthroplasty, Replacement, Hip; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Patient Safety; Postoperative Complications; Risk; Rivaroxaban; Thiophenes; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2013
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis. Thrombosis and haemostasis, 2013, Volume: 110, Issue:4 Topics: Acute Disease; Administration, Oral; Adult; Aged; Anticoagulants; Enoxaparin; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Patient Satisfaction; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism. Current medical research and opinion, 2014, Volume: 30, Issue:5 Topics: Anticoagulants; Enoxaparin; Female; Humans; Length of Stay; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis; Vitamin K	2014
[Effect of autologous drained blood reinfusion on hidden blood loss and limb swelling following rivaroxaban anticoagulation for primary total hip arthroplasty]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2014, Volume: 34, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Transfusion, Autologous; Edema; Female; Humans; Male; Middle Aged; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:7 Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2014, Volume: 41, Issue:2 Topics: Adult; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Patient Safety; Postoperative Care; Preoperative Care; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Statistics, Nonparametric; Survival Rate; Thiophenes; Treatment Outcome; Venous Thrombosis; Vitamin K; Warfarin	2014
The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial. The Journal of arthroplasty, 2017, Volume: 32, Issue:3 Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hematoma; Humans; Male; Middle Aged; Morpholines; Postoperative Hemorrhage; Postoperative Period; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Thiophenes; Tranexamic Acid; Venous Thrombosis	2017
A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor. The Journal of arthroplasty, 2017, Volume: 32, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Young Adult	2017
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. The New England journal of medicine, 2008, Jun-26, Volume: 358, Issue:26 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2008
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. The New England journal of medicine, 2008, Jun-26, Volume: 358, Issue:26 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2008
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. Blood, 2008, Sep-15, Volume: 112, Issue:6 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antithrombin III; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Rivaroxaban; Thiophenes; Treatment Outcome; Ultrasonography; Venous Thrombosis	2008
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet (London, England), 2009, 05-16, Volume: 373, Issue:9676 Topics: Administration, Oral; Aged; Analysis of Variance; Anticoagulants; Arthroplasty, Replacement, Knee; Double-Blind Method; Enoxaparin; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Morpholines; Phlebography; Risk Reduction Behavior; Rivaroxaban; Sensitivity and Specificity; Thiophenes; Treatment Outcome; Venous Thrombosis	2009
Oral rivaroxaban for symptomatic venous thromboembolism. The New England journal of medicine, 2010, Dec-23, Volume: 363, Issue:26 Topics: Acenocoumarol; Acute Disease; Administration, Oral; Aged; Anticoagulants; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Injections, Subcutaneous; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin	2010
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. Journal of thrombosis and thrombolysis, 2011, Volume: 31, Issue:4 Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Double-Blind Method; Female; Heart Failure; Humans; Infections; Male; Middle Aged; Morpholines; Pulmonary Embolism; Respiratory Insufficiency; Risk Factors; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2011
Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clinical pharmacokinetics, 2011, Volume: 50, Issue:10 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Body Weight; Computer Simulation; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Models, Biological; Morpholines; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis; Young Adult	2011
How safe is thromboprophylaxis in abdominoplasty? Plastic and reconstructive surgery, 2012, Volume: 130, Issue:6 Topics: Abdominoplasty; Administration, Oral; Adult; Anticoagulants; Double-Blind Method; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Follow-Up Studies; Hematoma; Humans; Middle Aged; Morpholines; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2012
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:11 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Arthroplasty, Replacement, Knee; Double-Blind Method; Enoxaparin; Hemorrhage; Humans; Incidence; Injections, Subcutaneous; Male; Middle Aged; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2005
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Dose-Response Relationship, Drug; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2006
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement. Thrombosis research, 2007, Volume: 120, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Phlebography; Postoperative Complications; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2007
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:7 Topics: Anticoagulants; Enoxaparin; Hip Prosthesis; Humans; Knee Prosthesis; Morpholines; Orthopedic Procedures; Phlebography; Postoperative Complications; Rivaroxaban; Sensitivity and Specificity; Thiophenes; Ultrasonography; Venous Thrombosis	2007

Other Studies

74 other study(ies) available for thiophenes and Deep Vein Thrombosis

Article	Year
[Rivaroxaban: Xarelto--recommendations for pharmacists]. Journal de pharmacie de Belgique, 2013, Issue:1 Topics: Anticoagulants; Humans; Morpholines; Pharmacists; Rivaroxaban; Thiophenes; Venous Thrombosis; Vitamin K	2013
More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban--early experience from King's College Hospital. British journal of haematology, 2013, Volume: 162, Issue:5 Topics: Anticoagulants; Humans; Morpholines; Thiophenes; Venous Thrombosis	2013
Successful treatment of acute portal vein thrombosis with rivaroxaban. Thrombosis and haemostasis, 2013, Volume: 110, Issue:4 Topics: Acute Disease; Anticoagulants; Disease-Free Survival; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Neovascularization, Physiologic; Portal Vein; Recovery of Function; Regional Blood Flow; Rivaroxaban; Thiophenes; Ultrasonography, Doppler, Duplex; Venous Thrombosis	2013
Phamacokinetics of rivaroxaban in adolescents. Hamostaseologie, 2014, Volume: 34, Issue:1 Topics: Adolescent; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Metabolic Clearance Rate; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism. Journal of medical economics, 2014, Volume: 17, Issue:1 Topics: Anticoagulants; Cost-Benefit Analysis; Drug Therapy, Combination; Enoxaparin; Humans; Markov Chains; Middle Aged; Morpholines; Quality-Adjusted Life Years; Rivaroxaban; Thiophenes; United States; Venous Thrombosis; Vitamin K	2014
[New direct oral anticoagulants and venous thromboprophylaxis]. La Revue du praticien, 2013, Volume: 63, Issue:7 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
New oral anticoagulants: an emergency department overview. Emergency medicine Australasia : EMA, 2013, Volume: 25, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Australia; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Service, Hospital; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2013
Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:9 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Humans; International Normalized Ratio; Male; Morpholines; Point-of-Care Systems; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
Rivaroxaban attenuates leukocyte adhesion in the microvasculature and thrombus formation in an experimental mouse model of type 2 diabetes mellitus. Thrombosis research, 2014, Volume: 133, Issue:2 Topics: Animals; Anticoagulants; Blood Coagulation; Cell Adhesion; Diabetes Mellitus, Type 2; Factor Xa Inhibitors; Female; Leukocytes; Mice; Microvessels; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thrombosis and haemostasis, 2014, May-05, Volume: 111, Issue:5 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Automation, Laboratory; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Equipment and Supplies; Factor VII; Hemorrhage; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Stroke; Thiophenes; Thrombelastography; Thrombin; Thrombin Time; Venous Thrombosis; Withholding Treatment	2014
Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:1 Topics: Acute Disease; Anticoagulants; Drug Administration Schedule; Humans; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Rivaroxaban; Thiophenes; Tomography, X-Ray Computed; Venous Thrombosis	2014
PROS1 mutations associated with protein S deficiency in Polish patients with residual vein obstruction on rivaroxaban therapy. Thrombosis research, 2014, Volume: 134, Issue:1 Topics: Adolescent; Adult; Blood Proteins; Female; Humans; Male; Morpholines; Mutation; Poland; Protein S; Protein S Deficiency; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
Venous gangrene and intravascular coagulation and fibrinolysis in a patient treated with rivaroxaban. The American journal of medicine, 2014, Volume: 127, Issue:6 Topics: Aged; Anticoagulants; Blood Coagulation; Female; Fibrinolysis; Gangrene; Humans; Lower Extremity; Morpholines; Neoplasms; Rivaroxaban; Thiophenes; Veins; Venous Thrombosis	2014
Protein S deficiency and novel oral anticoagulants: an intriguing case. Thrombosis research, 2014, Volume: 134, Issue:1 Topics: Blood Proteins; Female; Humans; Male; Morpholines; Protein S; Protein S Deficiency; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
A cost-analysis model for anticoagulant treatment in the hospital setting. Journal of medical economics, 2014, Volume: 17, Issue:7 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Factor Xa Inhibitors; Humans; Inpatients; Length of Stay; Models, Economic; Morpholines; Pulmonary Embolism; Randomized Controlled Trials as Topic; Retrospective Studies; Rivaroxaban; Thiophenes; United States; Venous Thrombosis; Warfarin	2014
Treating thrombosis in cirrhosis patients with new oral agents: ready or not? Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:2 Topics: Anticoagulants; Humans; Male; Mesenteric Veins; Morpholines; Portal Vein; Thiophenes; Venous Thrombosis	2015
First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia. Thrombosis research, 2015, Volume: 135, Issue:1 Topics: Aged; Blood Coagulation; Factor Xa Inhibitors; Female; Heparin; Heparin Antagonists; Humans; Kidney Failure, Chronic; Male; Middle Aged; Morpholines; Peripheral Vascular Diseases; Platelet Count; Renal Dialysis; Rivaroxaban; Thiophenes; Thrombocytopenia; Venous Thrombosis	2015
Thrombophilia testing, recurrent thrombosis, and women's health. Circulation, 2014, Jul-15, Volume: 130, Issue:3 Topics: Adult; Aged; Anticoagulants; Female; Humans; Male; Mass Screening; Morpholines; Mutation; Prothrombin; Recurrence; Risk Factors; Rivaroxaban; Thiophenes; Thrombophilia; Treatment Outcome; Venous Thrombosis; Warfarin; Women's Health	2014
[Treatment of acute deep vein thrombosis with new oral anticoagulant rivaroxaban: the first experience]. Khirurgiia, 2014, Issue:6 Topics: Acute Disease; Adult; Aged; Anticoagulants; Blood Coagulation; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Moscow; Prospective Studies; Rivaroxaban; Secondary Prevention; Thiophenes; Time Factors; Treatment Outcome; Venous Thrombosis	2014
Massive human rivaroxaban overdose. Thrombosis and haemostasis, 2014, Volume: 112, Issue:4 Topics: Administration, Oral; Chromatography, High Pressure Liquid; Drug Overdose; Factor Xa; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Rivaroxaban; Suicide, Attempted; Tandem Mass Spectrometry; Thiophenes; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2014
Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program. Journal of medical economics, 2014, Volume: 17, Issue:10 Topics: Adolescent; Adult; Aged; Anticoagulants; Enoxaparin; Female; Humans; Length of Stay; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; United States; Venous Thrombosis; Vitamin K; Young Adult	2014
Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke, 2014, Volume: 45, Issue:8 Topics: Adolescent; Adult; Aged; Anticoagulants; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Phenprocoumon; Rivaroxaban; Sinus Thrombosis, Intracranial; Thiophenes; Treatment Outcome; Venous Thrombosis; Young Adult	2014
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:4 Topics: Anticoagulants; Humans; Male; Mesenteric Veins; Morpholines; Portal Vein; Thiophenes; Venous Thrombosis	2015
Reply: To PMID 24395623. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:4 Topics: Anticoagulants; Humans; Male; Mesenteric Veins; Morpholines; Portal Vein; Thiophenes; Venous Thrombosis	2015
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thrombosis and haemostasis, 2014, Volume: 112, Issue:5 Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin	2014
Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA internal medicine, 2014, Volume: 174, Issue:10 Topics: Aged; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Female; Fracture Fixation, Internal; Hepatocytes; Humans; Hyperbilirubinemia; Liver; Male; Middle Aged; Morpholines; Necrosis; Primary Prevention; Rivaroxaban; Thiophenes; Tibial Fractures; Venous Thrombosis	2014
Use of nontraditional anticoagulants in portal vein thrombosis: a note of caution. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:6 Topics: Anticoagulants; Humans; Male; Mesenteric Veins; Morpholines; Portal Vein; Thiophenes; Venous Thrombosis	2015
Reply: To PMID 24395623. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:6 Topics: Anticoagulants; Humans; Male; Mesenteric Veins; Morpholines; Portal Vein; Thiophenes; Venous Thrombosis	2015
[Nephrotic syndrome revealed by pulmonary embolism: about four cases]. Annales de cardiologie et d'angeiologie, 2014, Volume: 63, Issue:5 Topics: Adult; Aged; Antithrombin III; Delayed Diagnosis; Drug Therapy, Combination; Echocardiography, Doppler; Fatal Outcome; Female; Humans; Kidney Function Tests; Male; Middle Aged; Morpholines; Nephrotic Syndrome; Prednisone; Proteinuria; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
Successful treatment of partial portal vein thrombosis (PVT) with low dose rivaroxaban. Zeitschrift fur Gastroenterologie, 2014, Volume: 52, Issue:10 Topics: Anticoagulants; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Middle Aged; Morpholines; Portal Vein; Radiography; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2014
[Application of rivaroxabane in patients with proteins C and S deficiency]. Khirurgiia, 2014, Issue:9 Topics: Adult; Anticoagulants; Blood Coagulation; Diosmin; Drug Combinations; Drug Monitoring; Female; Hesperidin; Humans; Male; Morpholines; Protein C Deficiency; Protein S Deficiency; Rivaroxaban; Thiophenes; Time; Treatment Outcome; Venous Thrombosis	2014
Mesenteric vein thrombosis caused by secondary polycythaemia from AndroGel. BMJ case reports, 2014, Oct-21, Volume: 2014 Topics: Abdominal Pain; Diagnosis, Differential; Humans; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Middle Aged; Morpholines; Polycythemia; Rivaroxaban; Testosterone; Thiophenes; Tomography, X-Ray Computed; Venous Thrombosis	2014
[Safety and efficacy of rivaroxaban for prevention of deep vein thrombosis in patients with preoperative abnormal D-dimer after total knee arthroplasty]. Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2014, Volume: 28, Issue:8 Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Humans; Knee Joint; Length of Stay; Morpholines; Osteoarthritis, Knee; Postoperative Complications; Postoperative Period; Preoperative Care; Prothrombin Time; Range of Motion, Articular; Rivaroxaban; Safety; Thiophenes; Venous Thrombosis	2014
Comparison of methods to determine rivaroxaban anti-factor Xa activity. Thrombosis research, 2015, Volume: 135, Issue:2 Topics: Adult; Cohort Studies; Factor Xa Inhibitors; Female; Humans; Male; Mass Spectrometry; Morpholines; Prospective Studies; Rivaroxaban; Thiophenes; Venous Thrombosis	2015
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. The American journal of gastroenterology, 2015, Volume: 110, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment	2015
[Extended options of anticoagulant treatment in thromboembolism]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:11 Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Czech Republic; Dabigatran; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2014
Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment. American journal of hematology, 2015, Volume: 90, Issue:7 Topics: Aged, 80 and over; Antibodies; Anticoagulants; Blood Platelets; Dalteparin; Female; Fondaparinux; Hip Fractures; Hirudins; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Morpholines; Peptide Fragments; Platelet Count; Polysaccharides; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombocytopenia; Venous Thrombosis	2015
Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment. Annals of hematology, 2015, Volume: 94, Issue:7 Topics: Adult; Antithrombin III Deficiency; Asparaginase; Delayed-Action Preparations; Humans; Male; Morpholines; Polyethylene Glycols; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2015
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clinical orthopaedics and related research, 2008, Volume: 466, Issue:8 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Azetidines; Benzylamines; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Pulmonary Embolism; Research Design; Rivaroxaban; Thiophenes; Venous Thrombosis	2008
New anticoagulants--the path from discovery to clinical practice. The New England journal of medicine, 2008, Jun-26, Volume: 358, Issue:26 Topics: Anticoagulants; Enoxaparin; Factor Xa Inhibitors; Humans; Morpholines; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2008
More effective, simpler-to-use clot-buster is on the way. Clot-prevention drug could save lives after joint replacement. DukeMedicine healthnews, 2008, Volume: 14, Issue:10 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Knee; Clinical Trials as Topic; Humans; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2008
[Summary and perspectives. Rivaroxaban]. Annales francaises d'anesthesie et de reanimation, 2008, Volume: 27 Suppl 3 Topics: Administration, Oral; Aged; Anticoagulants; Clinical Trials, Phase III as Topic; Comorbidity; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Humans; Kidney Failure, Chronic; Morpholines; Obesity; Postoperative Complications; Preanesthetic Medication; Rivaroxaban; Thiophenes; Thromboembolism; Thrombophilia; Venous Thrombosis	2008
The direct factor Xa inhibitor rivaroxaban. The Medical journal of Australia, 2009, Apr-06, Volume: 190, Issue:7 Topics: Administration, Oral; Anticoagulants; Drug Interactions; Factor Xa Inhibitors; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2009
Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:8 Topics: Animals; Benzimidazoles; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Morpholines; Pyrazoles; Pyridines; Pyridones; Rabbits; Rivaroxaban; Thiophenes; Thrombin; Venous Thrombosis	2009
Rivaroxaban versus enoxaparin after total knee arthroplasty. Lancet (London, England), 2009, Aug-29, Volume: 374, Issue:9691 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Drug Administration Schedule; Enoxaparin; Humans; Morpholines; Research Design; Rivaroxaban; Thiophenes; Venous Thrombosis	2009
Rivaroxaban versus enoxaparin after total knee arthroplasty. Lancet (London, England), 2009, Aug-29, Volume: 374, Issue:9691 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Knee; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Enoxaparin; Europe; Humans; Morpholines; North America; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thrombosis	2009
Rivaroxaban versus enoxaparin after total knee arthroplasty. Lancet (London, England), 2009, Aug-29, Volume: 374, Issue:9691 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Enoxaparin; Hemorrhage; Humans; Morpholines; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Rivaroxaban; Safety; Thiophenes; Venous Thrombosis	2009
New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness? PharmacoEconomics, 2009, Volume: 27, Issue:10 Topics: Anticoagulants; Benzimidazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Dabigatran; Economics, Pharmaceutical; Humans; Morpholines; Pyridines; Rivaroxaban; Thiophenes; Venous Thrombosis	2009
DVT: a new era in anticoagulant therapy. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:3 Topics: Animals; Anticoagulants; Benzimidazoles; Dabigatran; Disease Models, Animal; Factor Xa Inhibitors; Humans; Mice; Mice, Knockout; Morpholines; Pyridines; Rivaroxaban; Thiophenes; Thrombin; Venous Thrombosis	2010
Antithrombotic and anticoagulant profiles of TAK-442, a novel factor Xa inhibitor, in a rabbit model of venous thrombosis. Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:2 Topics: Animals; Anticoagulants; Azetidines; Benzylamines; Bleeding Time; Blood Coagulation; Blood Coagulation Tests; Dogs; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Morpholines; Pyrazoles; Pyridones; Pyrimidinones; Rabbits; Rats; Rats, Sprague-Dawley; Rivaroxaban; Sulfones; Thiophenes; Thrombin; Venous Thrombosis	2010
Oral rivaroxaban for symptomatic venous thromboembolism. The New England journal of medicine, 2011, 03-24, Volume: 364, Issue:12 Topics: Acute Disease; Administration, Oral; Anticoagulants; Enoxaparin; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Recurrence; Risk Assessment; Rivaroxaban; Thiophenes; Venous Thrombosis	2011
Review of an article: oral rivaroxaban for symptomatic venous thromboembolism. The EINSTEIN Investigators et al. N Engl J Med 2010; 363(26):2499-2510. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing, 2011, Volume: 29, Issue:2 Topics: Anticoagulants; Factor Xa Inhibitors; Humans; Morpholines; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thrombosis	2011
Oral direct factor Xa inhibitor gets FDA's OK. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Aug-15, Volume: 68, Issue:16 Topics: Administration, Oral; Anticoagulants; Drug Approval; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; United States; United States Food and Drug Administration; Venous Thrombosis	2011
Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays. Thrombosis and haemostasis, 2011, Volume: 106, Issue:5 Topics: Administration, Oral; Anticoagulants; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Dose-Response Relationship, Drug; Factor VIII; Factor Xa Inhibitors; Humans; Morpholines; Netherlands; Partial Thromboplastin Time; Predictive Value of Tests; Prothrombin Time; Rivaroxaban; Thiophenes; Time Factors; Venous Thrombosis	2011
Rivaroxaban: direct factor Xa inhibition to treat acute deep vein thrombosis. British journal of hospital medicine (London, England : 2005), 2011, Volume: 72, Issue:9 Topics: Acute Disease; Anticoagulants; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Rivaroxaban; Thiophenes; Venous Thrombosis	2011
[New treatments for venous thromboembolic disease]. Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thrombosis; Warfarin	2011
Oral thromboprophylaxis in pelvic trauma: a standardized protocol. The Journal of emergency medicine, 2012, Volume: 43, Issue:4 Topics: Adult; Aged; Anticoagulants; Drug Administration Schedule; Female; Fractures, Bone; Glasgow Coma Scale; Humans; Injury Severity Score; Lower Extremity; Male; Middle Aged; Morpholines; Pelvic Bones; Pulmonary Embolism; Radionuclide Imaging; Rivaroxaban; Thiophenes; Time Factors; Ultrasonography; Venous Thrombosis; Young Adult	2012
Coagulopathies and thrombosis: usual and unusual causes and associations, part VI. Seminars in thrombosis and hemostasis, 2012, Volume: 38, Issue:2 Topics: Acute Coronary Syndrome; Altitude; Blood Coagulation Disorders; Coffee; Factor Xa Inhibitors; Heparin; Humans; Lipoproteins; Lymphatic Diseases; Morpholines; Myocardial Infarction; Platelet Aggregation Inhibitors; Rivaroxaban; Thiophenes; Thrombocytopenia; Thrombosis; Troponin; Venous Thrombosis; von Willebrand Diseases	2012
Determination of rivaroxaban in human plasma samples. Seminars in thrombosis and hemostasis, 2012, Volume: 38, Issue:2 Topics: Blood Coagulation; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Partial Thromboplastin Time; Prothrombin Time; Rivaroxaban; Thiophenes; Venous Thrombosis	2012
[Therapy of pulmonary embolism. Rivaroxaban is superior to standard therapy]. MMW Fortschritte der Medizin, 2012, Apr-19, Volume: 154, Issue:7 Topics: Anticoagulants; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thrombosis	2012
Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. The Journal of bone and joint surgery. American volume, 2012, Sep-05, Volume: 94, Issue:17 Topics: Age Distribution; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cerebral Hemorrhage; Cohort Studies; Confidence Intervals; Databases, Factual; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Morpholines; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Assessment; Rivaroxaban; Sex Distribution; Surgical Wound Infection; Survival Analysis; Thiophenes; Treatment Outcome; Venous Thrombosis; Wound Healing	2012
Pneumococcal vaccines; use of rivaroxaban for DVT and PE. JAAPA : official journal of the American Academy of Physician Assistants, 2012, Volume: 25, Issue:7 Topics: Anticoagulants; Humans; Morpholines; Pneumococcal Vaccines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2012
Rivaroxaban delivery and reversal at a venous flow rate. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:12 Topics: Administration, Oral; Anticoagulants; Blood Flow Velocity; Dose-Response Relationship, Drug; Factor V; Factor Va; Factor Xa; Humans; Models, Biological; Morpholines; Regional Blood Flow; Risk Factors; Rivaroxaban; Thiophenes; Thromboplastin; Venous Thrombosis	2012
[Questions--answers on the use of rivaroxaban for the treatment of venous thromboembolic disease]. Journal des maladies vasculaires, 2012, Volume: 37, Issue:6 Topics: Age Factors; Anticoagulants; Drug Interactions; Factor Xa; France; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Risk Factors; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Vitamins	2012
New oral anticoagulants. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Mar-05, Volume: 185, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Canada; Contraindications; Dabigatran; Drug Dosage Calculations; Drug Interactions; Humans; Morpholines; Postoperative Complications; Pyridines; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
Extensive venous thrombosis in a healthy young man with a short inferior vena cava syndrome treated successfully with rivaroxaban. BMJ case reports, 2012, Nov-15, Volume: 2012 Topics: Adult; Anticoagulants; Edema; Enoxaparin; Humans; Iliac Vein; Incidental Findings; Male; Morpholines; Rivaroxaban; Thiophenes; Tomography, X-Ray Computed; Travel; Vena Cava, Inferior; Venous Thrombosis; Warfarin; Young Adult	2012
Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry. Thrombosis and haemostasis, 2013, Volume: 109, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Fibrinolytic Agents; Germany; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Kaplan-Meier Estimate; Length of Stay; Logistic Models; Male; Middle Aged; Morpholines; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Registries; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; Thromboembolism; Time Factors; Treatment Outcome; Venous Thrombosis	2013
[Impact of ivaroxaban on hidden blood loss and blood transfusion rate after primary total knee arthroplasty]. Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2012, Volume: 26, Issue:11 Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Hemoglobins; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Morpholines; Osteoarthritis, Knee; Postoperative Complications; Postoperative Hemorrhage; Range of Motion, Articular; Retrospective Studies; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2012
Normal prothrombin time in the presence of therapeutic levels of rivaroxaban. British journal of haematology, 2013, Volume: 160, Issue:6 Topics: Aged; Anticoagulants; Humans; Morpholines; Prothrombin Time; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:3 Topics: Animals; Blood Coagulation Tests; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Inhibitory Concentration 50; Morpholines; Rabbits; Rats; Rivaroxaban; Serine Proteinase Inhibitors; Species Specificity; Thiophenes; Thromboplastin; Venous Thrombosis	2005
Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor. Thrombosis and haemostasis, 2007, Volume: 97, Issue:3 Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation Tests; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Humans; Infusions, Intravenous; Injections, Intravenous; Jugular Veins; Ligation; Morpholines; Nadroparin; Polysaccharides; Rabbits; Random Allocation; Rivaroxaban; Thiophenes; Thromboplastin; Venous Thrombosis	2007
Development of oral anticoagulants. British journal of clinical pharmacology, 2007, Volume: 64, Issue:3 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Drug Delivery Systems; Drug Design; Enoxaparin; Factor Xa Inhibitors; Humans; Morpholines; Postoperative Hemorrhage; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin	2007
Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors. Journal of medicinal chemistry, 2007, Jun-28, Volume: 50, Issue:13 Topics: Amides; Aminopyridines; Animals; Anticoagulants; Crystallography, X-Ray; Dogs; Factor Xa Inhibitors; Humans; In Vitro Techniques; Male; Models, Molecular; ortho-Aminobenzoates; Prothrombin Time; Rats; Rats, Wistar; Structure-Activity Relationship; Thiophenes; Venous Thrombosis	2007
RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit. Thrombosis and haemostasis, 1999, Volume: 81, Issue:1 Topics: Animals; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Partial Thromboplastin Time; Rabbits; Sulfonamides; Thiophenes; Venous Thrombosis	1999